A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide
Clinical trial NCT00234520 · COMPLETED
Trial details
- NCT number
- NCT00234520
- Sponsor
- Ipsen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2003-05-01
- Primary completion
- 2005-02-18
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.